Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.

Current drug targets. CNS and neurological disorders

Volumn 1, Issue 4, 2002, Pages 337-348

  Astles, P C ^a   Baker, S R ^a   Boot, J R ^a   Broad, L M ^a   Dell, C P ^a   Keenan, M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AZOCINE DERIVATIVE; CYTISINE; EPIBATIDINE; FUSED HETEROCYCLIC RINGS; LIGAND; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PYRIDINE DERIVATIVE; QUINOLIZINE DERIVATIVE;

ANIMAL; CHEMISTRY; DRUG EFFECT; HUMAN; REVIEW;

ALKALOIDS; ANIMALS; AZOCINES; BICYCLO COMPOUNDS, HETEROCYCLIC; HUMANS; LIGANDS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; QUINOLIZINES; RECEPTORS, NICOTINIC;

EID: 0038210322     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007023339256     Document Type: Review

References (83)